Bio Protocol vs Stable — how do they compare? Bio Protocol trades at Rp443.47 (market cap Rp1T, Rp172,7M 24h volume), while Stable trades at Rp601.73 (market cap Rp15,26T, Rp202,63M 24h volume). The key difference: Stable is far larger — about 15.3× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Stable's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Stable for 5 Days on average.
| BIO | STABLE | |
|---|---|---|
Market Cap | Rp1T | Rp15,26T |
Volume (24h) | Rp172,7M | Rp202,63M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 25,4B STABLE |
Typical Hold Time | 17 Days | 5 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
STABLE is currently trading at Rp596.08 with a market cap of Rp15.06 trillion, showing a bearish technical signal overall as moving averages indicate selling pressure while oscillators are neutral. The asset is trading near resistance at Rp593, with key support at Rp561. No major protocol updates or ecosystem developments were noted recently.
The outlook remains cautious due to bearish technical indicators and lack of fundamental catalysts. Key risks include high volatility and limited liquidity, while potential opportunities may arise if support levels hold. Investors should monitor for any network updates or shifts in market sentiment.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Stable is a high-throughput Layer-1 blockchain built for real-world financial use cases, institutional settlement, and consumer-scale transactions. It uses USDT as gas, offers deterministic blockspace guarantees, and runs on a validator architecture built for reliability, transparency, and sustainable rewards.
Read more on STABLE →